genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Latest
All
More
Drug Discovery
StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery
ASGCT 2024: SalioGen’s Nonviral In Vivo Gene Insertion Technology Takes Preclinical Strides
Drug Discovery
Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial
OMICs
Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard
Artificial Intelligence
Viral Advantage: Prologue Medicines is Here to Release the Viral Proteome’s Therapeutic Potential
Drug Discovery
StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Drug Discovery
ASGCT 2024: Moonwalk Biosciences Presents Multiplex Epigenetic Engineering Platform
Drug Discovery
Novartis to Acquire Mariana for Up to $1.75B, Expanding Radiopharma Pipeline
Cancer
The Upside Down: Delphia Therapeutics Launches to Treat Cancer with Activation Lethality
Drug Discovery
Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?
Drug Discovery
Ono to Expand Cancer Portfolio with $2.4B Deciphera Acquisition
Drug Discovery
StockWatch: Biogen Q1 Results Beat Expectations, for a Change
Artificial Intelligence
Insilico Targets MTAP Deleted Cancers with AI-Designed Candidate
Genome Editing
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration
OMICs
StockWatch: PacBio Faces Uphill Climb as Q1 Revenue Falls Short
OMICs
Bruker to Acquire NanoString with $392.6M Winning Bid
Artificial Intelligence
At Bio-IT World 2024, AI Applications Take Center Stage
Drug Discovery
Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders
Drug Discovery
StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Cancer
Earli Detection: “Synthetic” Biomarkers Light Up Hidden Malignant Cancers
Genome Editing
China Upholds Key CVC CRISPR Patent Licensed through ERS Genomics
Drug Discovery
Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline
GEN Edge
CRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Tools
Drug Discovery
Seaport Therapeutics Launches with $100M Series A
Cancer
AACR 2024: Geneos Therapeutics’ Vaccine Outperforms Liver Cancer Immunotherapies
Genome Editing
Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo
GEN Edge
Bittersweet Symphony: Verve’s Pause on VERVE-101 Narrows LNP-Delivery Strategy
Genome Editing
StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles
Artificial Intelligence
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Cancer
AACR 2024: Insilico Medicine to Present Preclinical Data for AI-Generated Cancer Drugs
Load more
Scroll Up